ORIX Corporation
ORXCF
$20.96
$2.0310.72%
Weiss Ratings | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Reward Grade | C+ | |||
Rating Factors | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Excellent | |||
Growth Index | Weak | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.07 | |||
Price History | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 15.97% | |||
30-Day Total Return | -4.73% | |||
60-Day Total Return | 3.40% | |||
90-Day Total Return | -3.85% | |||
Year to Date Total Return | -12.99% | |||
1-Year Total Return | 3.37% | |||
2-Year Total Return | 17.58% | |||
3-Year Total Return | 16.50% | |||
5-Year Total Return | 40.18% | |||
52-Week High % Change | -30.76% | |||
52-Week Low % Change | 4.74% | |||
Price | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $27.34 | |||
52-Week Low Price | $18.07 | |||
52-Week Low Price (Date) | Feb 19, 2025 | |||
52-Week High Price (Date) | Sep 03, 2024 | |||
Valuation | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 24.08B | |||
Enterprise Value | 60.92B | |||
Price/Earnings (TTM) | 10.30 | |||
Earnings Per Share (TTM) | 1.84 | |||
Earnings Per Share Growth | 0.74% | |||
Price/Earnings To Growth | 14.10 | |||
Price/Sales (TTM) | 1.50 | |||
Price/Book (Q) | 0.79 | |||
Enterprise Value/Revenue (TTM) | 4.20 | |||
Price | $20.96 | |||
Enterprise Value/EBITDA (TTM) | 13.39 | |||
Enterprise Value/EBIT | 23.26 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 1.15B | |||
Dividend Yield | 328.42% | |||
Div. Per Share (Most Recent) | $62.17 | |||
Dividend Per Share (TTM) | $62.17 | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | $62.17 | |||
Company Info | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 81 3 3435 3000 | |||
Address | -- | |||
Website | www.orix.co.jp | |||
Country | Japan | |||
Year Founded | 1950 | |||
Profitability | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | $12.65 | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | -1.03% | |||
Earnings Growth (Q YOY) | 41.75% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | 45.69% | |||
Balance Sheet | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 8.29B | |||
Cash Per Share (Q) | $7.22 | |||
Total Current Assets (Q) | 48.12B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 27.79B | |||
Current Ratio (Q) | 4.109 | |||
Book Value Per Share (Q) | $23.86 | |||
Total Assets (Q) | 114.06B | |||
Total Current Liabilities (Q) | 11.71B | |||
Total Debt (Q) | 43.57B | |||
Total Liabilities (Q) | 86.26B | |||
Total Common Equity (Q) | 27.24B | |||
Cash Flow | ORXCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||